S1 Ep8: Part 2 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with David Gandara MD
S1 Ep8: Part 3 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Charu Aggarwal MD, MPH
S1 Ep8: Part 4 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Julia Rotow MD
S1 Ep7: Part 5 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Balazs Halmos MD, MS
S1 Ep6: Tumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer
S1 Ep5: Managing Your Patients with CKD
S1 Ep4: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment